Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer Model. [electronic resource]
Producer: 20161018Description: 84-93 p. digitalISSN:- 1538-8514
- Animals
- Antineoplastic Agents -- administration & dosage
- Capillary Permeability -- drug effects
- Cell Line, Tumor
- Disease Models, Animal
- Doxorubicin -- administration & dosage
- Drug Carriers
- Humans
- Liposomes
- Mice
- Nanoparticles
- Neovascularization, Pathologic -- drug therapy
- Pancreatic Neoplasms -- drug therapy
- Polyethylene Glycols -- administration & dosage
- Receptors, G-Protein-Coupled -- antagonists & inhibitors
- Smoothened Receptor
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.